Home Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard
Article
Licensed
Unlicensed Requires Authentication

Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard

  • Sheena Blackmore , Malcolm Hamilton , Anne Lee , Mark Worwood , Matthew Brierley , Alan Heath and Susan J. Thorpe
Published/Copyright: October 1, 2008

Abstract

Background: Ferritin standardisation is problematical due to the heterogeneity of ferritin isoforms and the antibodies used in its immunoassay, and the lack of a reference measurement procedure. We investigated the performance of the 1st (liver), 2nd (spleen) and 3rd (recombinant) International Standards (ISs) for ferritin in major assays.

Methods: The ferritin in a serum pool ‘spiked’ with either the 2nd or 3rd IS for ferritin was measured by 52 laboratories using five automated methods and the recovery of the target values calculated. A smaller serum pool was ‘spiked’ with the 1st IS for a limited recovery exercise. The ferritin values of five serum samples were also measured and recalculated relative to the ISs.

Results: Recoveries of each of the 2nd and 3rd ISs were 90%–110% for four of five methods; recoveries of the 1st IS were 104% and 111% for two of three methods claiming traceability to this IS. One method significantly over-recovered each of the IS (124%–155%). Recalculating the ferritin values of the serum samples relative to the IS reduced the overall inter-method agreement, largely because of the anomalous over-recovery of the IS by one method.

Conclusions: The use of the 3rd IS to standardise assays will minimise assay drift due to manufacturers adopting a ‘harmonisation’ approach in which the calibration is adjusted to conform to overall mean values. Standardisation against the current IS also ensures compliance with the European Union In-Vitro Diagnostic Directive which requires traceability of assay calibrators to reference materials of a higher order. Assay drift may result in poor sensitivity and specificity in the diagnosis of iron status, and would require laboratories to continually re-evaluate reference intervals.

Clin Chem Lab Med 2008;46:1450–7.


Corresponding author: Susan J. Thorpe, Biotherapeutics Group, NIBSC, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK Fax: +44-1707-647227,

Received: 2008-3-18
Accepted: 2008-7-4
Published Online: 2008-10-01
Published in Print: 2008-10-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
  3. Minireview
  4. Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?
  5. Genetics and Molecular Diagnostics
  6. Association between the 2756A> G variant in the gene encoding methionine synthase and myocardial infarction in Tunisian patients
  7. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects
  8. New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia
  9. Enzyme-free signal amplification of analyte in a single closed tube by fluorescent hybridization chain reaction
  10. Five X-chromosome short tandem repeats in a Western Mexican population
  11. General Clinical Chemistry and Laboratory Medicine
  12. Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis
  13. Methionine metabolism in an animal model of sepsis
  14. Hypochlorous acid is a potent inactivator of human plasminogen at concentrations secreted by activated granulocytes
  15. Association of serum γ-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults
  16. Immunoradiometric determination of thyroglobulin in serum samples by time calibration transfer
  17. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients
  18. Measurement of 10,11-dihydro-10-hydroxy-carbamazepine in serum and plasma by high-performance liquid chromatography
  19. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population
  20. Reference Values and Biological Variations
  21. Analytical quality goals for parathyroid hormone based on biological variation
  22. Preanalytical effects of pneumatic tube transport on routine haematology, coagulation parameters, platelet function and global coagulation
  23. Validation and Outcome Studies
  24. Automated immunoassay methods for ferritin: recovery studies to assess traceability to an international standard
  25. An expert system for the classification of serum protein electrophoresis patterns
  26. Impact of a satellite laboratory on turnaround times for the emergency department
  27. Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins
  28. Guidelines and Recommendations
  29. Protein standardization V: value transfer. A practical protocol for the assignment of serum protein values from a Reference Material to a Target Material
  30. Letter to the Editor
  31. Biological variability evaluation and comparison of three different methods for C-peptide measurement
  32. Abstracts
  33. 10.1515/CCLM.2008.361
Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.304/html?lang=en
Scroll to top button